NeuroSense Therapeutics (NRSN) Short Interest Ratio & Short Volume → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free NRSN Stock Alerts $1.23 -0.03 (-2.38%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media NeuroSense Therapeutics Short Interest DataCurrent Short Volume88,400 sharesPrevious Short Volume63,700 sharesChange Vs. Previous Month+38.78%Dollar Volume Sold Short$135,252.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 15, 2024Outstanding Shares13,670,000 sharesFloat Size11,600,000 sharesShort Percent of Float0.76%Today's Trading Volume42,146 sharesAverage Trading Volume196,170 sharesToday's Volume Vs. Average21% Short Selling NeuroSense Therapeutics ? Sign up to receive the latest short interest report for NeuroSense Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNRSN Short Interest Over TimeNRSN Days to Cover Over TimeNRSN Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself NeuroSense Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202488,400 shares $135,252.00 +38.8%0.8%0.3 $1.53 3/31/202463,700 shares $115,934.00 +81.5%0.7%0.2 $1.82 3/15/202435,100 shares $48,438.00 -83.4%0.4%0.1 $1.38 2/29/2024211,400 shares $374,178.00 +42.0%2.3%0.5 $1.77 2/15/2024148,900 shares $198,037.00 +12.7%1.6%0.2 $1.33 1/31/2024132,100 shares $165,125.00 -35.6%1.5%0.2 $1.25 Get the Latest News and Ratings for NRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024205,200 shares $175,261.32 -17.7%2.3%0.2 $0.85 12/31/2023249,200 shares $195,622.00 +18.7%2.7%0.3 $0.79 12/15/2023210,000 shares $176,631.00 +1.9%2.3%0.2 $0.84 11/30/2023206,100 shares $265,869.00 -11.9%2.3%0.3 $1.29 11/15/2023234,000 shares $120,276.00 +89.3%2.6%1 $0.51 10/31/2023123,600 shares $56,930.16 +182.2%1.4%0.6 $0.46 10/15/202343,800 shares $23,956.67 +91.3%0.5%0.3 $0.55 9/30/202322,900 shares $16,259.00 -3.8%0.3%0.3 $0.71 9/15/202323,800 shares $20,944.00 +9.2%0.3%0.6 $0.88 8/31/202321,800 shares $20,492.00 +77.2%0.2%0.5 $0.94 8/15/202312,300 shares $11,808.00 -37.6%0.1%0.2 $0.96 7/31/202319,700 shares $25,610.00 -53.4%0.3%0.3 $1.30 7/15/202342,300 shares $57,528.00 -38.3%0.6%0.5 $1.36 6/30/202368,600 shares $102,214.00 -12.4%1.0%0.9 $1.49 6/15/202378,300 shares $144,072.00 -38.8%1.2%1 $1.84 5/31/2023127,900 shares $199,524.00 -13.6%1.9%1.9 $1.56 5/15/2023148,000 shares $253,080.00 -1.7%2.2%2.9 $1.71 4/30/2023150,600 shares $304,212.00 -12.0%2.2%2 $2.02 4/15/2023171,100 shares $278,893.00 -8.2%2.5%1.4 $1.63 3/31/2023186,300 shares $320,436.00 -6.1%2.8%0.1 $1.72 3/15/2023198,300 shares $354,957.00 -6.4%3.1%0.1 $1.79 2/28/2023211,800 shares $393,948.00 -10.1%3.1%0.2 $1.86 2/15/2023235,700 shares $393,619.00 +8.2%3.4%0.2 $1.67 1/31/2023217,900 shares $337,745.00 +1,479.0%3.2%0.2 $1.55 1/15/202313,800 shares $18,630.00 -25.0%0.2%0 $1.35 12/30/202218,400 shares $22,448.00 -24.6%0.3%0.7 $1.22 12/15/202224,400 shares $37,332.00 -22.0%0.4%0.8 $1.53 11/30/202231,300 shares $53,836.00 +30.4%0.5%0.9 $1.72 11/15/202224,000 shares $40,800.00 -21.8%0.4%0.6 $1.70 10/31/202230,700 shares $49,120.00 -40.0%0.5%0.8 $1.60 10/15/202251,200 shares $87,552.00 -53.7%0.7%0.7 $1.71 9/30/2022110,500 shares $197,795.00 +269.6%1.6%1.1 $1.79 9/15/202229,900 shares $61,893.00 +13.7%0.4%0 $2.07 8/31/202226,300 shares $51,285.00 -46.8%0.4%0 $1.95Protect Your Bank Account Before It’s Too Late (Ad)For months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself NRSN Short Interest - Frequently Asked Questions What is NeuroSense Therapeutics' current short interest? Short interest is the volume of NeuroSense Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 88,400 shares of NRSN short. 0.76% of NeuroSense Therapeutics' shares are currently sold short. Learn More on NeuroSense Therapeutics' current short interest. What is a good short interest percentage for NeuroSense Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.76% of NeuroSense Therapeutics' floating shares are currently sold short. Is NeuroSense Therapeutics' short interest increasing or decreasing? NeuroSense Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 88,400 shares, an increase of 38.8% from the previous total of 63,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NeuroSense Therapeutics' float size? NeuroSense Therapeutics currently has issued a total of 13,670,000 shares. Some of NeuroSense Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NeuroSense Therapeutics currently has a public float of 11,600,000 shares. How does NeuroSense Therapeutics' short interest compare to its competitors? 0.76% of NeuroSense Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NeuroSense Therapeutics: Flora Growth Corp. (7.33%), KALA BIO, Inc. (0.21%), FSD Pharma Inc. (1.11%), Galecto, Inc. (0.09%), Alaunos Therapeutics, Inc. (9.51%), Orgenesis Inc. (1.17%), Benitec Biopharma Inc. (0.50%), Minerva Neurosciences, Inc. (0.56%), BioVie Inc. (2.78%), Aptorum Group Limited (1.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short NeuroSense Therapeutics stock? Short selling NRSN is an investing strategy that aims to generate trading profit from NeuroSense Therapeutics as its price is falling. NRSN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NeuroSense Therapeutics? A short squeeze for NeuroSense Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NRSN, which in turn drives the price of the stock up even further. How often is NeuroSense Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRSN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Flora Growth Short Interest Data KALA BIO Short Interest Data FSD Pharma Short Interest Data Galecto Short Interest Data Alaunos Therapeutics Short Interest Data Orgenesis Short Interest Data Benitec Biopharma Short Interest Data Minerva Neurosciences Short Interest Data BioVie Short Interest Data Aptorum Group Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRSN) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe World's First "$20 Trillion Drug?"Behind the Markets